Mold-Tek Packaging Ltd. delivered a robust performance in the first quarter of FY26, with its net profit surging 37.67% sequentially to ₹22.40 crore, compared to ₹16.27 crore in Q4 FY25. The packaging major benefited from strong demand momentum, operational efficiencies, and continued expansion in its pharma and food segments.
Revenue from operations rose to ₹240.56 crore, marking an 18.73% growth quarter-on-quarter, driven by healthy sales across all verticals. EBITDA came in at ₹47.38 crore, registering a 21.24% rise from ₹39.08 crore in the previous quarter. The company’s EBITDA margin also remained strong, reflecting improved capacity utilisation and cost control measures.
Sales volume reached 11,378 metric tonnes (MT), up 16.89% from 9,734 MT in Q4 FY25. Mold-Tek’s Pharma-Packaging business led the charge, growing more than nine times year-on-year, according to the company’s release.
Profit before tax (PBT) stood at ₹30.01 crore, up 35.02% from ₹22.23 crore in the previous quarter. The company’s strong bottom-line growth was supported by increased operational leverage and a favorable product mix.
With a positive start to FY26, the company reaffirmed its strategic focus on the pharma and FMCG segments, where demand remains resilient. Mold-Tek also highlighted ongoing investments in automation and capacity enhancements, aiming to further strengthen its market leadership in rigid plastic packaging.
The company has expressed optimism about sustaining growth in upcoming quarters, particularly with festive demand expected to pick up in the second half of the fiscal.